IRMA-International.org: Creator of Knowledge
Information Resources Management Association
Advancing the Concepts & Practices of Information Resources Management in Modern Organizations

Homology Modeling and Binding Site Analysis of SARS-CoV-2 (COVID-19) Main Protease 3D Structure

Homology Modeling and Binding Site Analysis of SARS-CoV-2 (COVID-19) Main Protease 3D Structure
View Sample PDF
Author(s): Marion Olubunmi Adebiyi (Landmark University, Omuo-Aran, Nigeria)and Ibidun Christiana Obagbuwa (Sol Plaajte University, Kimberley, South Africa)
Copyright: 2024
Pages: 15
Source title: Research Anthology on Bioinformatics, Genomics, and Computational Biology
Source Author(s)/Editor(s): Information Resources Management Association (USA)
DOI: 10.4018/979-8-3693-3026-5.ch038

Purchase

View Homology Modeling and Binding Site Analysis of SARS-CoV-2 (COVID-19) Main Protease 3D Structure on the publisher's website for pricing and purchasing information.

Abstract

The severe acute respiratory syndrome coronavirus 2 (SAR-Cov-2) caused the coronavirus (COVID-19) pandemic. The global concern is the discovery of a new target drug for the total cure. Recently, some research showed that a few COVID-19 enzymes may have been contemplated to be potential drug targets, but not much is known about its structural biology. This research investigates the 3-D structure of protease SAR-CoV-2. The tertiary structure was determined by homology modeling. The Swiss-Model workspace and the basic local alignment search tool (BLAST) were employed for modeling, and the resulted model was validated with programs that include PROCHECK, Verify3D, and QMEAN to ascertain reliability. To establish the structures that fitted, HHBlits software was employed. To verify the structure quality, a Ramachandran plot was exploited. The binding site was determined using CASTp and DeepSite algorithms, which showed that this protein can be exploited as a prospective pharmaceutical target. Albeit further experimentation is required as a COVID-19 virus vaccine-design/target-drug.

Related Content

Linkon Chowdhury, Md Sarwar Kamal, Shamim H. Ripon, Sazia Parvin, Omar Khadeer Hussain, Amira Ashour, Bristy Roy Chowdhury. © 2024. 20 pages.
Mousomi Roy. © 2024. 21 pages.
Nassima Dif, Zakaria Elberrichi. © 2024. 20 pages.
Pyingkodi Maran, Shanthi S., Thenmozhi K., Hemalatha D., Nanthini K.. © 2024. 16 pages.
Mohamed Nadjib Boufenara, Mahmoud Boufaida, Mohamed Lamine Berkane. © 2024. 16 pages.
Meroua Daoudi, Souham Meshoul, Samia Boucherkha. © 2024. 25 pages.
Zhongyu Lu, Qiang Xu, Murad Al-Rajab, Lamogha Chiazor. © 2024. 56 pages.
Body Bottom